IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model MiceTiffany J. Mellott, Jan Krzysztof Blusztajn|PLoS ONE|2014Cited by 94
Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model MiceTiffany J. Mellott, Jan Krzysztof Blusztajn|PLoS ONE|2017Cited by 56